LIM-0705
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LIM-0705, covering 2010-06-07 to 2011-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR [Phase 2]